N-terminally modified analogues of glucose-dependent insulinotropic polypeptide exhibit improved insulinotropic activity and antihyperglycaemic potential compared with glucagon-like peptide-1 counterparts

Victor Gault, BD Green, B Greer, P Harriott, Peter Flatt, Finbarr O'Harte

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)545
Issue numberSuppl.
Publication statusPublished (in print/issue) - Aug 2002

Bibliographical note

38th EASD Annual Meeting of the European-Association-for-the-Study-of-Diabetes, BUDAPEST, HUNGARY, SEP
01-05, 2002

Cite this